Anthony A.. Florence Jr's Net Worth

$890 Million

Estimate Recalculated Apr 25, 2024 05:48PM EST

Who is Anthony A.. Florence Jr?

Anthony A.. Florence Jr has an estimated net worth of $890 Million. This is based on reported shares across multiple companies, which include Arcellx, Inc., Berkshire Grey, Inc., Oyster Point Pharma, Inc., IonQ, Inc., Nightstar Therapeutics plc, Reneo Pharmaceuticals, Inc., Galera Therapeutics, Inc., IMARA Inc., ZeroFox Holdings, Inc., Senti Biosciences, Inc.\, Mersana Therapeutics, Inc., CHAMPIONS ONCOLOGY, INC., Surface Oncology, Inc., Desktop Metal, Inc., Cascadian Therapeutics, Inc., MULESOFT, INC, Robinhood Markets, Inc., Nkarta, Inc., Bright Health Group Inc., Verona Pharma plc, Monte Rosa Therapeutics, Inc., AVEO PHARMACEUTICALS, INC., APPIAN CORP, Mirum Pharmaceuticals, Inc., Adaptimmune Therapeutics PLC, Loxo Oncology, Inc., GENOCEA BIOSCIENCES, INC., Metacrine, Inc., Inozyme Pharma, Inc., Millendo Therapeutics, Inc., Eargo, Inc., ARDELYX, INC., Savara Inc, Trevi Therapeutics, Inc., Tracon Pharmaceuticals, Inc., Annexon, Inc., SYNLOGIC, INC., Akouos, Inc., Black Diamond Therapeutics, Inc., Arsanis, Inc., Cerecor Inc., Regulus Therapeutics Inc., ARCA biopharma, Inc., Marker Therapeutics, Inc., Casper Sleep Inc., Strongbridge Biopharma plc, CVENT INC, Achaogen Inc, Care.com Inc, INTERLEUKIN GENETICS INC, and Korro Bio, Inc..

SEC CIK

Anthony A.. Florence Jr's CIK is 0001559827

Past Insider Trading and Trends

2018 was Anthony A.. Florence Jr's most active year for acquiring shares with 50 total transactions. Anthony A.. Florence Jr's most active month to acquire stocks was the month of May. 2021 was Anthony A.. Florence Jr's most active year for disposing of shares, totalling 52 transactions. Anthony A.. Florence Jr's most active month to dispose stocks was the month of December. 2022 saw Anthony A.. Florence Jr paying a total of $378,955,496.36 for 18,601,468 shares, this is the most they've acquired in one year. In 2019 Anthony A.. Florence Jr cashed out on 78,321,254 shares for a total of $169,898,090.01, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Berkshire Grey, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-38.18M
—
—
0
Jul 20
Form 3
—
0
—
—
0
No matching records found

Nightstar Therapeutics plc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-6.66M
$25.50
-$169,894,566.00
0
Jun 7
Form 3
—
0
—
—
0
No matching records found

Reneo Pharmaceuticals, Inc. (RPHM) Snapshot price: $1.64

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
4.79M
$15.00
—
4.79M
Apr 13
Form 3
—
0
—
—
0
No matching records found

Arcellx, Inc. (ACLX) Snapshot price: $64.51

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-29.65%
-2.00M
$30.74
$5,501.96
4.75M
Dec 20 - Dec 21
Form 4
+4.86%
312.5K
$16.00
$5,000,000.00
6.75M
Jun 21
Form 4
∞
6.43M
$15.00
$23,749,995.00
6.43M
Feb 8
Form 3
—
0
—
—
0
No matching records found

Oyster Point Pharma, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+1,737.54%
5.6M
$16.00
—
5.93M
Nov 4
Form 3
—
0
—
—
0
No matching records found